130 related articles for article (PubMed ID: 8438240)
21. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
Maeda H; Ogoshi S; Fujimoto S
Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
[No Abstract] [Full Text] [Related]
22. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine kinase-dependent lymphocyte signaling during allograft rejection.
Coles J; Tsao P; Wilson G; Mills G
Transplant Proc; 1993 Feb; 25(1 Pt 2):877. PubMed ID: 8442253
[No Abstract] [Full Text] [Related]
24. T cell suppression in transplantation tolerance through linked recognition.
Davies JD; Leong LY; Mellor A; Cobbold SP; Waldmann H
J Immunol; 1996 May; 156(10):3602-7. PubMed ID: 8621893
[TBL] [Abstract][Full Text] [Related]
25. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
[No Abstract] [Full Text] [Related]
27. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
[No Abstract] [Full Text] [Related]
28. Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells.
Shirwan H; Mhoyan A; Yolcu ES; Que X; Ibrahim S
Transpl Immunol; 2003; 11(2):179-85. PubMed ID: 12799202
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive effect of soluble class I antigen and its complexes with monoclonal antibody on advanced heart graft rejection in rats.
Sumimoto R; Kamada N
Transplant Proc; 1991 Feb; 23(1 Pt 1):86-8. PubMed ID: 1990706
[No Abstract] [Full Text] [Related]
30. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW
Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313
[No Abstract] [Full Text] [Related]
31. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
[No Abstract] [Full Text] [Related]
32. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
Lee R; Glimcher LH; Auchincloss H
Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
[No Abstract] [Full Text] [Related]
33. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
Duguid IG; Koulmanda M; Mandel TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
[No Abstract] [Full Text] [Related]
34. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
35. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
[No Abstract] [Full Text] [Related]
36. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
[TBL] [Abstract][Full Text] [Related]
37. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts.
Henretta J; Araneda D; Pittman K; Thomas F
Transplant Proc; 1995 Feb; 27(1):1303-4. PubMed ID: 7878892
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition of heart allograft rejection by serum from liver-grafted rats.
Kamada N; Shinomiya T; Tamaki T
Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823
[No Abstract] [Full Text] [Related]
39. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
[No Abstract] [Full Text] [Related]
40. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
